IDEXX Laboratories says the new tests will gradually roll out through 2026. IDEXX Laboratories says the new tests will ...

The IDEXX Cancer Dx Panel has already transformed cancer screening for veterinarians. Today, more than 5,500 practices across ...

IDEXX Laboratories Inc. (Nasdaq: IDXX) has developed a diagnostic test to help veterinarians detect kidney injury in cats and dogs at an earlier stage to improve treatment. The Westbrook-based ...

IDEXX Laboratories exceeded earnings and revenue estimates on sales of its animal testing products and price increases. The ...

IDEXX Laboratories, Inc. IDXX recently expanded its Fecal Dx antigen testing platform with the addition of Cystoisospora — a common intestinal parasite that is the source of diarrhea, weight loss and ...

IDEXX Laboratories is expected to release its fiscal fourth-quarter earnings soon, and analysts project a double-digit ...

IDEXX Laboratories is a leader in animal diagnostics, boasting strong recurring revenue and nearly 50% stock gains year-to-date. IDXX's innovation pipeline, robust cash position, and global reach ...